Search

Your search keyword '"Thyssen, Jacob P"' showing total 2,850 results

Search Constraints

Start Over You searched for: Author "Thyssen, Jacob P" Remove constraint Author: "Thyssen, Jacob P"
2,850 results on '"Thyssen, Jacob P"'

Search Results

201. 350 Examining the relationships among abrocitinib treatment, itch, skin pain and work and activity impairments in patients with atopic dermatitis: a mediation modelling analysis

202. 351 Examining the relationships among abrocitinib treatment, itch, skin pain and dermatology-specific quality of life in patients with atopic dermatitis: a mediation modelling analysis

203. Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials

204. Access to psoriasis treatment in Brazil and Chile: A cross-sectional multi-centre `Global Healthcare Study on Psoriasis

207. Short‐term real‐world experience with baricitinib treatment in Danish adults with moderate–severe atopic dermatitis

209. Safety of upadacitinib in moderate-to-severe atopic dermatitis: An integrated analysis of phase 3 studies

211. The European baseline series and recommended additions: 2023

212. Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials

213. Skin TARC/CCL17 increase precedes the development of childhood atopic dermatitis

214. Comorbidities in Chilean patients with psoriasis: a Global Healthcare Study on Psoriasis

215. Validity and reliability of the Rosacea Area and Severity Index: A novel scoring system for clinical assessment of rosacea severity

217. Conjunctivitis in adolescent patients aged 12–17 with moderate-to-severe atopic dermatitis treated with tralokinumab up to week 52: results from the phase 3 ECZTRA 6 trial

225. 651 - Improvement of the head and neck regions with continuous tralokinumab treatment for up to 4 years in adults with moderate-to-severe atopic dermatitis.

226. Prevalence of ichthyoses in Denmark: a nationwide registry-based study.

227. Clinical characteristics of combined rosacea and migraine

228. Comorbidities of atopic dermatitis-what does the evidence say?

231. Multivariable Predictive Models to Identify the Optimal Biologic Therapy for Treatment of Patients With Psoriasis at the Individual Level

233. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD™): a clinical outcome measure for the severity of atopic dermatitis

237. Skin biomarkers predict development of atopic dermatitis in infancy

238. Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce

242. 32496 Efficacy and safety of abrocitinib according to geographies

Catalog

Books, media, physical & digital resources